Prof. Dr. Ersin Özaslan
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Colorectal Neoplasms 8 publicationsSource: OpenAlex / PubMed MeSHView publications
- Adenocarcinoma 5 publications
- Lung Neoplasms 4 publications
- Adenoma 3 publications
- Pituitary Neoplasms 3 publications
- Neoplasms 3 publications
- Breast Neoplasms 3 publications
- Neuroendocrine Tumors 3 publications
- Liver Neoplasms 3 publications
- Gastrointestinal Neoplasms 2 publications
- Carcinoma, Renal Cell 2 publications
- Kidney Neoplasms 2 publications
- Colonic Neoplasms 2 publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.
- Akciğer, Akciğer Zarı Kanserleri (Mezotelyoma) ve Diğer Torasik Kanserler
- Kolorektal Kanserler (Kolon ve Rektum Kanseri)
- Meme Kanseri
- Mesane Kanseri
- Prostat Kanseri
- Jinekolojik Tümörler ve Kanserler (Rahim, Serviks, Yumurtalık/Over Kanseri vb.)
- Yumurtalık (Over) Kanseri
- Mide Kanseri
- Akciğer Kanseri
- Kolon (Kalın Bağırsak) Kanseri
CV
Education and experience
Experience
- 2018Acıbadem Sağlık Grubuacibadem.com.tr
- 2016 - 2018Kayseri Eğitim Araştırma Hastanesi / Tıbbi Onkolojiacibadem.com.tr
Education
- 2016Erciyes Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
- 2012Erciyes Üniversitesi Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
- 2007İstanbul Üniversitesi İstanbul Tıp Fakültesi, Üniversiteacibadem.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyMedical Oncologyacibadem.com.trFrom source
- InstitutionAcıbadem Kayseri Hastanesiacibadem.com.trFrom source
- Area of workColorectal NeoplasmsExtracted from 8 publications · Model version —From source
- Publications53 publicationsOpenAlexFrom source
- Last synchronised4 November 2026 20:54https://www.acibadem.com.tr/doktor/ersin-ozaslan/acibadem.com.tr
Scientific work
Publications on Colorectal Neoplasms
-
Tumor Volume Is a Better Prognostic Factor than Greatest Tumor Diameter in Operated Stage I-III Non–Small-Cell Lung Cancer
Clinical Lung Cancer, 2023
DOI 10.1016/j.cllc.2023.02.009 PMID 37019814 4 citations (Europe PMC) Source: OpenAlex
-
Is SUVmax of 18F-FDG PET/CT Predictive Factor for Malignancy in Gastrointestinal Tract?
Nigerian Journal of Clinical Practice, 2021
DOI 10.4103/njcp.njcp_637_18 PMID 34397034 4 citations (Europe PMC) Source: OpenAlex
-
A single-center observational study assessing the predictive factors associated with the prognosis of acromegaly
Growth Hormone & IGF Research, 2020
DOI 10.1016/j.ghir.2020.101342 PMID 32916586 6 citations (Europe PMC) Source: OpenAlex
-
Chemotherapy at the End of Life
Journal of Palliative Care, 2020
DOI 10.1177/0825859720946505 PMID 32762320 11 citations (Europe PMC) Source: OpenAlex
-
Comorbidity and polypharmacy in patients with breast cancer
Breast Cancer, 2020
DOI 10.1007/s12282-019-01040-8 PMID 31898155 19 citations (Europe PMC) Source: OpenAlex
-
The role of primary tumor resection in patients with stage IV colorectal cancer with unresectable metastases.
PubMed, 2020
PMID 32521889 7 citations (Europe PMC) Source: OpenAlex
-
Breast carcinoma detected in breast specimens: A fifteen-year single-center experience
Annals of Medical Research, 2019
DOI 10.5455/annalsmedres.2019.05.287 Source: OpenAlex
-
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.
PubMed, 2019
PMID 31786850 1 citation (Europe PMC) Source: OpenAlex
-
Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)
Clinical and Applied Thrombosis/Hemostasis, 2018
DOI 10.1177/1076029617753538 PMID 29455568 4 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Rechallenge chemotherapy as a third line treatment option for metastatic colorectal carcinoma
Ortadoğu Tıp Dergisi, 2017
DOI 10.21601/ortadogutipdergisi.296006 Source: OpenAlex